Canature Health Technology Group Co., Ltd. Class A

Canature Health Technology Group Co., Ltd. Class A

SSZSE:300272
5.19
CNY
+0.04
(+0.78%)
-0.03EPS
3.71BMarket Cap

Total Valuation

CNY

As of September 30, 2026, Canature Health Technology Group Co., Ltd. Class A carries a market capitalization of 3.71B, placing it among publicly traded companies globally. Its enterprise value stands at 4.29B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap3.71B
Enterprise Value4.29B

Share Statistics

As of September 30, 2026, Canature Health Technology Group Co., Ltd. Class A has 611.47M shares outstanding.

Shares Outstanding611.47M

Valuation Ratios

These figures are as of September 30, 2026. The price-to-sales ratio is 2.00, and the price-to-book ratio stands at 3.05.

PS Ratio2.00
PB Ratio3.05
P/TBV Ratio3.86

Enterprise Valuation

As of September 30, 2026, Canature Health Technology Group Co., Ltd. Class A trades at an EV/EBITDA multiple of 604.14 - the valuation measure that neutralizes differences in capital structure, tax rates, and depreciation policy, making it the standard yardstick for comparing companies across an industry. The EV/Sales ratio of 2.31 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. Its EV/EBIT multiple of 604.14 values the business against core operating earnings after depreciation, a stricter test than EV/EBITDA for capital-intensive businesses. These enterprise value multiples are built on an enterprise value of 4.29B versus a market cap of 3.71B, with the gap driven by net debt and cash on the balance sheet.

EV / Sales2.31
EV / EBITDA604.14
EV / EBIT604.14

Financial Position

As of September 30, 2026, Canature Health Technology Group Co., Ltd. Class A maintains a current ratio of 0.98, meaning it holds 1.0x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 114.99, indicating elevated leverage, while an interest coverage ratio of 0.14 demonstrates limited ability to service its debt obligations.

Current Ratio0.98
Quick Ratio0.63
Debt / Equity114.99
Debt / EBITDA216.23
Interest Coverage0.14

Financial Efficiency

CNY

Over the twelve months ended September 30, 2026, Canature Health Technology Group Co., Ltd. Class A posted a negative return on equity (ROE) of -4.13, meaning shareholder capital produced losses rather than profits. Return on invested capital (ROIC) is negative at -0.57, so the business is destroying capital rather than earning a return above its cost of capital. Return on assets (ROA) is negative at -1.51, reflecting losses generated across the asset base. Return on capital employed (ROCE) is negative at -7.00, pointing to unprofitable operations over the period. The company generates approximately 1.23M in revenue per employee across its workforce of 1,510.00, a quick read on workforce productivity versus industry peers. Inventory turnover of 3.71 indicates how many times Canature Health Technology Group Co., Ltd. Class A sells and replaces its inventory over a year, a key working capital efficiency ratio.

Return on Equity (ROE)-4.13
Return on Assets (ROA)-1.51
Return on Invested Capital (ROIC)-0.57
Return on Capital Employed (ROCE)-7.00
Revenue Per Employee1.23M
Employee Count1,510.00
Inventory Turnover3.71

Taxes

CNY

Over the twelve months ended September 30, 2026, Canature Health Technology Group Co., Ltd. Class A recorded 30.80M in income tax expense. That works out to an effective tax rate of 315.15, which can sit above or below the statutory corporate tax rate depending on foreign earnings mix, tax credits, and one-off items. Taxes are levied on pretax income of 9.77M, leaving -51.08M in net income after tax - the gap is what shifts in the tax rate do to reported earnings and EPS.

Income Tax30.80M
Effective Tax Rate315.15

Stock Price Statistics

CNY

As of the close on November 17, 2026, Canature Health Technology Group Co., Ltd. Class A's stock has declined approximately 34.14% over the past 52 weeks. The 50-day moving average sits at 5.58, while the 200-day moving average is 6.50.

52-Week Price Change-34.14%
50-Day Moving Average5.58
200-Day Moving Average6.50

Income Statement

CNY

Over the twelve months ended September 30, 2026, Canature Health Technology Group Co., Ltd. Class A generated 1.86B in revenue and converted that into -51.08M in net income, yielding earnings per share of -0.03. EBITDA reached 7.11M, while operating income came in at 182.55M.

Revenue1.86B
Gross Profit721.41M
Operating Income182.55M
Pretax Income9.77M
Net Income-51.08M
EBITDA7.11M
EBIT7.11M
Earnings Per Share (EPS)-0.03

Balance Sheet

CNY

As of September 30, 2026, Canature Health Technology Group Co., Ltd. Class A holds 1.07B in cash and equivalents against 1.54B in total debt, resulting in a net debt position of 266.75M. Total book value stands at 1.21B, with working capital of -30.08M providing operational flexibility.

Cash & Cash Equivalents1.07B
Total Debt1.54B
Net Debt266.75M
Equity (Book Value)1.21B
Book Value Per Share1.98
Working Capital-30.08M

Cash Flow

CNY

These figures cover the twelve months ended September 30, 2026.

Capital Expenditures-120.81M

Margins

Over the twelve months ended September 30, 2026, Canature Health Technology Group Co., Ltd. Class A posted a gross margin of 38.84, reflecting its pricing power and cost economics. The operating margin of 9.83 and net profit margin of -2.75 provide insight into operational efficiency.

Gross Margin38.84
Operating Margin9.83
Pretax Margin0.53
Profit Margin-2.75
EBITDA Margin0.38

Dividends & Yields

CNY

Over the twelve months ended September 30, 2026, Canature Health Technology Group Co., Ltd. Class A paid dividends of 0.17 per share. The dividend payout ratio of 1,120.73 exceeds 100%, meaning the company is distributing more than it earns and funding the dividend from cash reserves, asset sales, or borrowing, a key gauge of how sustainable the dividend is and how much room remains for future dividend growth. Total shareholder yield reaches 1.56, combining dividends paid with share buybacks and debt reduction for a fuller picture of capital returned to Canature Health Technology Group Co., Ltd. Class A shareholders.

Dividend Per Share0.17
Payout Ratio1,120.73
Shareholder Yield1.56

Stock Splits

Canature Health Technology Group Co., Ltd. Class A's most recent stock split took place on June 21, 2019 with a 5:6 split ratio.

Last Split Date6/21/2019
Split Ratio5:6

Scores

As of September 30, 2026, Canature Health Technology Group Co., Ltd. Class A has an Altman Z-Score of 1.82, near the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score1.82